Axion BioSystems, Inc. Overview
Pro stress-test →Axion BioSystems is a leading biotechnology company that develops and commercializes advanced live-cell analysis platforms for use in biomedical research and drug discovery. The company's award-winning products are designed to accelerate scientific breakthroughs and transform therapeutic development from discovery to manufacturing.
Strategic Profile
Pro stress-test →The company's core technologies include multiwell microelectrode array (MEA) systems and impedance-based assays that enable real-time, label-free monitoring of cellular activity in vitro. The company's flagship Maestro systems are used globally by academic institutions, pharmaceutical companies, and CROs for applications such as neurotoxicity screening, cardiac safety profiling, and disease modeling.
Competitive Landscape
Pro stress-test →Competitors of Axion BioSystems include 20/20 BioLabs, OrganoTherapeutics, AgaMatrix, Optovue, and Intuity Medical. The company differentiates through integrated multielectrode array and imaging solutions with established customer relationships in academic and pharmaceutical research.
Industry Context
Axion BioSystems, Inc. operates in Life Science Research Tools & Cell Analysis Platforms.
Key facts
Founded: 2008 · Headquarters: Atlanta, US · Employees: 180 · Revenue: $20.1M